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The present study served to investigate the ability of seven selective muscarinic antagonists to inhibit carbachol-in-
duced drinking in the rat. The muscarinic antagonists were given by intracerebroventricular (i.c.v.) injection 1 min 
before the i.c.v. injection of carbachol (1 p.gjrat). The M2 antagonist, methoctramine, was inactive up to 80.3 
nmoljrat. The M3 antagonist, p-fluoro-hexahydro-sila-difenidol, elicited a modest (42%) but statistically significant 
inhibition of drinking only at 80 nmoljrat. On the other band, the selective M1 antagonists, (R)-trihexyphenidyl, 
o-methoxy-sila-hexocyclium and pirenzepine, produced a marked and dose-dependent inhibition of carbachol-induced 
drinking, their 1050 values being 0.51. 7.36 and 9.31 nmoljrat. Also the M1/M 3 antagonists, 4-diphenylacetoxy-N-
methylpiperidine methiodide and hexahydro-sila-difen.idol, were potent inhibitors of carbachol-induced drinking, their 
I 0 50 values (0.28 and 11.09 nmoljrat) being related to their pA 2 values for M1 receptors in rabbi t vas deferens. These 
data suggest that carbachol-induced drinking may be mediated by activation of muscarinic M1 receptors. 
Carbachol-induced drinking; Muscarinic receptor antagonists; Muscarinic receptor subtypes; 
Muscarinic M1 receptors; Musearlnie M2 receptors; Muscarinic M3 receptors 
1. Introduction 
The first indication of muscarinic receptor het-
erogeneity was derived from studies on agonist 
binding (Birdsall et al., 1980). However, agonist 
binding curves are difficult to interpret in terms of 
receptor subtypes, owing to the complexity of 
agonist-receptor interaction, involving both differ-
ent affinity states and coupling proteins. The dis-
covery of antimuscarinic compounds which are 
selective for certain tissues or organs provided a 
more reliable approach to the subclassification of 
Correspondence to: C. Melchiorre, Departmenl of Phanna-
ceulicaJ Sciences, University of Bologna, Via Belmeloro 6, 
40126 Bologna, ltaly. 
muscanmc receptors. On this basis, these recep-
tors have been classified into at least three sub-
types: M1 (Hammer and Giachetti, 1982), M 2 
(M 20 , Mutschier et al., 1988; M2A, Eglen and 
Whiting, 1986) and M3 (M 2ß, Mutschier et al., 
1988; M28, Eglen and Whiting, 1982) according to 
Doods et al. (1987). Pirenzepine shows higher 
affinity for M1 receptors than for the M2 and M 3 
types (Hammer and Giachetti, 1982), methoctra-
mine displays high selectivity for the M 2 type 
(Melchiorre et al., 1987; Melchiorre, 1988; in press; 
Michel and Whiting, 1988), whereas hexahydro-
sila-difenidol and 4-diphenylacetoxy-N-methyl-
piperidine methiodide (4-DAMP) show higher af-
finity for M 3 and M1 types than for M 2 receptors 
(Eitze and Figala, 1988; Mutschier et al., 1988; 
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Barlow et al., 1976). More recently, Lambrecht et 
al. (1988a, b, c) have developed the highly selec-
tive M 3 muscarinic antagonist, p-fluoro-hexahy-
dro-sila-difenidol, as weil as the very potent and 
selective M1 muscarinic antagonists, o-methoxy-
sila-hexocyclium and (R)-trihexyphenidyl. 
The centrat administration of acetylcholine 
agonists not only has several effects on the regu-
lation of body fluids and of blood pressure in the 
rat: Stimulation of water intake, inhibition of salt 
appetite, release of vasopressin but in addition, 
produces a neuregenie hypertensive response (for 
review see Fitzsimons, 1979; Simpson, 1986). The 
understanding of the functional relationships be-
tween these effects can only be understood if the 
receptor subtype involved is known. Selective 
pharmacological manipulations of these functions 
also can only be carried out with knowledge of the 
subtype of receptor involved in each of the above 
mentioned effects. On the basis of the available 
evidence that drinking induced by acetylcholine 
agonists is mediated by muscarinic receptors 
(Fitzsimons, 1979). and taking advantage of the 
variety of selective muscarinic antagonists men-
tioned above. we designed the present study to 
investigate the subtype of muscarinic receptor in-
volved in carbachol-induced drinking. An earlier 
investigation bad provided indications that M 2 
receptors may not be involved (Massi et al., 1989) 
in the response. 
2. Materials and methods 
2.1. Anima/s 
Male albino Wistar rats (Charles River, Calco 
Corno, Italy) averaging 250-275 g at the beginning 
of the experiments were housed individually in a 
temperature-controlled room on a 12: 12 Iight-
dark cycle. Food in pellets (MILL, Morini, Reggio 
Emilia, ltaly) and tap water were available ad 
libitum. 
2.2. Drugs 
The following drugs were used: carbachol 
(carbamoylcholine chloride) (Merck), (Ile 5]angio-
tensin II (Peninsula Lab. Inc. ); pirenzepine { 5,11-
dihydro-11-[( 4-methyl-l-piperazinyl)-acetyl]-6H-
pyrido[2,3-b](1.4)benzodiazepin-6-one} dihydro-
chloride and (R)-trihexyphenidyl hydrochloride 
were kindly supplied by Dr. A. Giachetti and Dr. 
A.J. Aasen, respectively; methoctramine {N .N '-
bis[6-[[(2-methoxybenzyl]amino]hexyl}-1,8-octane-
diamine tetrahydrochloride, 4-DAMP ( 4-diphenyl-
acetoxy-N-methylpiperidine methiodide), hexa-
hydro-sila-difenidol [cyclohexylphenyl(3-piperi-
donopropyl) silanol hydrochloride], p-fluoro-
hexahydro-sila-difenidol [cyclohexy(4-fluoro-
phenyl)(3-piperidinopropyl)silanol] and o-meth-
oxy-sila-hexocyclium ( 4-{ [cyclohexylhydroxy(2-
methoxyphenyl)silyl]methyl} -1, 1-dimethylpipera-
zinium methyl sulfate) were all synthesized in our 
laboratories. 
2.3. Surgery and intracranial injections 
All the animals were anesthetized (Equithesin, 
3 mljkg body weight i.p.) and fitted by Stereotaxie 
surgery with a stainless-steel cannula ( o.d. 600 
p.m) aimed at 1 mm above the lateral ventricle. 
The guide cannula was attached to the skull by 
means of jewelry screws and dental acrylic ce-
ment. The rats were aiJowed one week to recover 
from surgery before testing began. 
The drugs to be tested were dissolved in sterile 
isotonic saline, with the exception of hexahydro-
sila-difenidol and p-fluoro-hexahydro-sila-difen-
idol that were dissolved in distilled water. being 
slightly soluble in isotonic saline. The drugs were 
given by intracerebroventricular (i.c.v.) injection 
through a stainless-steel injector (o.d. 300 p.m) 
temporarily inserted into the guide cannula and 
protruding 2 mm beyond the cannula tip. This 
technical expedient was adopted in order to re-
duce the possibility of back-flow of the solutions 
into the guide cannula. All the drugs were given in 
a constant volume of 1 p.l, except hexahydro-sila-
difenidol and p-fluoro-hexahydro-sila-difenidol 
that were given in a 2-1-ll volume. 
2.4. Experimental pro<:edure 
2.4.1. Effect of muscarinic antagonists on carbachol-
induced drinking 
Carbachol {lp.gjrat) was administered by i.c.v. 
injection to water-replete rats 1 min after the i.c.v. 
administration of a muscanmc antagonist or of 
vehicle (controls). After carbachol injection, the 
animals were retumed to their home cages where 
water and food were freely available. Water intake 
was recorded over a 2-h period of observation. For 
each antagonist, the experiment was carried out 
according to a 'within subjecf design, in which 
each rat received all the doses of antagonists as 
weil as the vehicle used for the antagonist itself. 
The rats were tested twice a week. Different groups 
of animals were used for the different antagonists. 
2. 4. 2. Effect of muscarinic antagonists on angioten-
sin 11-induced drinking 
(Ilc5]Angiotensin II was given by i.c.v. injection 
to water-replete rats at the dose of 100 ngjrat. 
Again, muscarinic antagonists or simple vehicle 
were administered i.c.v. 1 min before (lle5)angio-
tensin II administration. Water intake was re-
corded for 60 min after the second i.c.v. injection. 
Only one dose of antagonist, the highest tested 
versus carbachol-induced drink.ing, was used. Each 
animal was also tested with the appropriate vehlcle. 
2. 5. Statistical analysis 
The data are reported as means ± S.E.M. Stat-
istical analysis of data for each compound tested 
was done by multifactorial analysis of variance 
(repeated measures) to check the overall signifi-
cance of drug treatment. Planned pairwise com-
parisons were carried out by means of t-tests. 
Statistical significance was set at P < 0.05. 
3. Results 
3. 1. Effect of muscarinic antagonists on carbacho/-
induced drinking 
Carbachol, given by pulse i.c. v. injection at a 
dose of 1 p.gjrat, induced copious drinking within 
1 or 2 min following injection. Most of the dipso-
genic response was expressed in the first 60-min 
period. However, additional drinkingwas also de-
tected in several animals in the 2nd h of observa-





Fig. 1. Percent inhibition induced by differ~nt doses of 4-
DAM P, ( R)-trihexyphenidyl (THP). o-methoxy-sila-hexo-
cyclium (o-MeSiHC), pirenzepine (PZ). hexahydro-sila-difen-
idol (HHSiD), p-fluoro-hexahydro-sila-difenidol (pFHHSiD) 
and methoctrarnine (Metho) of drinking induced by carbachol 
(1 JLg/rat). The values are means ± S.F..M. for 6-10 subjects. 
The inhibitions reported were determined at 120 min after 
carbachol administration. Difference from controls (vehicle + 
carbachol): • P < 0.05; •• P < 0.01; where not indicated, the 
difference from controls was not statistically significant. 
ranged between 8 and 12 ml of water ;rat in the 
different experimental groups. 
Figure 1 shows the dose-response relationships 
for the inhibitory effect of the muscarinic 
antagonists on carbachol-induced drinking. To 
compare the effects of these antagonists. water 
intake was expressed as percent of that of the 
controls and doses are reported in nmoljrat. 
The potency (expressed as -log 1050 ) of the 
seven antagonists tested to inhibit carbachol-in-
duced drinking is reported in table 1. In the range 
of doses tested, none of the muscarinic antagonists 
evoked evident behavioural alterations that might 
have prevented the animal from drinking. 
As seen in previous experiments (Massi et al., 
1989), the selective M2 antagonist, methoctra-
mine, produced a very slight inhibition of 
carbachol-induced drinking, in the range of doses 
from 3.3 to 80.3 nmoljrat (2.5-60 p.gjrat). The 
overall analysis of variance revealed the absence 
of a statistically significant drug effect, together 
with the absence of drug-time interaction. In the 
present study 60 p.g/rat was the highest dose of 
methoctramine tested, as we observed that admin-
istration of 100 p.gjrat plus carbachol 1 p.g pro-
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TABLE 1 
Comparison of -log 1050 values (with 95% conridence Iimits (c.l.)) of muscarinic antagonists tested on carbachol-induced drinking. 
with their pA 2 values at M1 (rabbit vas deferens), M2 (guinea-pig left atria) and M3 (guinea-pig or rat ileum) receptors. Data taken 
from • Eltze and Figala (1988), b Melchiorre et al. (1987), c Lambrecht et al. (1988a). d Lambrecht et al. (1988c). c Lambrecht et al. 
(1988b), r Eltze (1988), and 1 Eglen and Whiting (1986). h Binding affinities (pKi values) at M1/M 2 /M 3 receptors, (R)-tri-
hexyphenidyl: 9.0j7.7j8.1; 4-DAMP: 9.1/8.1/8.9 (Waelbroeck et al., 1988; 1989) 
Antagonist -log 1050 
(95% c.l.) 
Methoctramine < 7.1 
p-Fluoro-hexahydro-sila-difenidol < 7.1 
Pirenzepine 8.03 (7.63; 8.44) 
Hexahydro-sila-difenidol 7.96 (7.41; 8.50) 
o-Methoxy-sila-hexocycü um 8.13 (7.98; 8.28) 
(R)-Trihexyphenidyl h 9.29 (7.90; 10.68) 
4-0AMP h 9.55 (9.19; 9.90) 
duced heavy prostration~ followed by episodes of 
intense locomotor Stimulation often ending in ro-
tations along the rat's longitudinal axis. The Mr 
selective antagonist, p-fluoro-hexahydro-sila-di-
fenidol. evoked a slight and statistically not sig-
nificant inhibition of carbachol-induced drinking 
at doses up to 40 nmoljrat (15.4 J.Lgfrat)- A 
significant drug effect was detected only in re-
sponse to 80 nmoljrat (F(1,7) = 14.27; P < 0.01); 
pairwise comparisons showed that the inhibitory 
effect was significant throughout the 2-h period of 
observation. Even at this dose, however, the in-
hibition was less than 50%. Higher doses were not 
tested because of problems related to drug solubil-
ity. On the other band, the five other muscarinic 
antagonists tested evoked a marked suppression of 
carbachol-induced drinking, the mostpotent being 
4-DAMP and (R)·trihexyphenidyl. The overall 
analyis of variance revealed a powerful effect of 
4-DAMP in the range of doses tested (F(3,15) = 
6.93; P < 0.005). Following the lowest dose of 0.06 
nmoljrat (31 ngjrat) the intake of treated rats 
wa~. lower, but statistically indistinguishable from 
that of the controls_ The inhibitory effect. on the 
other band, was very pronounced and statistically 
significant at the dose of 0.276 and 1.10 nmoljrat. 
The time course of the drinking inhibition induced 
by 4-DAMP is shown in fig. 2. The 1050 of the 
drug on carbachol-induced drinking was 0.288 
nmol (95% confidence Iimits (c.l.): 0.127-0.650). 
The selective M1 antagonist. (R)-trihexyphenidyl, 
pA2 
Mt M2 MJ 
6.85. 8.13 h 5.69 b 
6.68 c 6.01 c 7.84 c 
8.24c 6.82 c 6.88 c 
7.92 c 6.53 c 7.96 c 
8.31 d 6.41 d 6.96 d 
10.11 c 8.15 e 8.68 c 
9.12 r 7.90 I 9.0 I 
was tested in the range of doses of 0.1, 1 and 10 
nmoljrat (0.03-3.37 1-Lg/rat). The inhibitory effect 
at the lowest dose tested was significant up to 60 
min following carbachol injection. The higher do-
ses significantly inhibited drinking throughout the 
2-h period of observation. The 1050 of the drug 
was 0.51 nmol (95% c.l.: 0.021-12.51). The M1-
selective antagonist, o-methoxy-sila-hexocyclium, 
was about 10 times less potent than (R)-tri-
hexyphenidyl. lt did not evoke significant inhibi-
tion of drinking at the dose of 1 nmoljrat (0.47 

















0 15 30 120 
TIME. min 
Fig. 2. Timecourse of drinking inducd by carbachol (1 #'g/rat) 
following pretreatment with isotonic saline (ISO) or with dif-
ferent doses (nmoljrat) of 4-DAMP. Difference from controls: 
• P < 0.05: • • P < 0.01; where not indicated the difference 
from controls was not statistically significant. 
100 nmoljrat. The 1050 of o-methoxy-sila-hexo-
cyclium was 7.36 nmol (95% c.l.: 5.19-10.45). The 
M1-selective antagonist, pirenzepine, was slightly 
less potent than o-methoxy-sila-hexocyclium. In 
the range of doses tested, 1.17-94.2 nmol/rat (0.5-
40 pgjrat), it produced a highly significant effect 
(F(4,20) = 36.64; P < 0.0001). The effect was sig-
nificant throughout the 2-h period of observation 
even at the dose of 1.17 nmol. The I 0 50 of 
pirenzepine was 9.31 nmol (95% c.l.: 3.66-23.67). 
Finally. hexahydro-sila-difenidol proved to be es-
sentially as potent as pirenzepine, its 1050 being 
11.09 nmol (95% c.l.: 3.15-39.03). 
3.2. Effect of muscarinic antagonists on angiotensin 
1/-induced drinking 
To exclude the possibility that the muscarinic 
antagonists tested might have inhibited carbachol-
induced drinking by producing a behavioural im-
pairment, the same drugs were tested on angio-
tensin-induced drinking. For each drug we tested 
the highest dose used versus carbachol-induced 
drinking. Angiotensin I I evoked a very prompt 
dipsogenie response, within 15-60 s. Most of the 
drinking occurred in the first 15 min after i.c.v. 
injection and was usually complete in the first 30 
min in most of the rats treated. The water intake 
TABLE 2 
Cumulative water intake in 60 min following i.c.v. injection of 
(lle5)angiotensin II (100 ngjrat) in rats pretreated with 
musearlnie antagonists (doses in nmoljrat) or with simple 
vehicle 
Antagonist (dose) Water intake (mljrat) a 
Vehicle Antagonist 
Methoctramine (80.3) 16.0±2.1 21.2 ± 1.6 
p-Fluoro-hexahydro-sila-
difenidol (80) 15.5 ± 1.2 17.2 ± 2.1 
Pirenzepine (94.2) 14.2± 1.6 16.6 ± 1.6 
Hexahydro-sila-di fenidol 
(108.6) 17.0±2.0 14.2± 3.5 
o-Methox y-sila-hexocyclium 
(100) 16.1 ± 2.8 15.1±1.6 
( R)-Trihexyphenidyl (1 0) 14.1 ± 3.2 17.2± 1.0 
4-DAMP (1.1) 17.1 ±2.5 15.2± 2.0 
a The difference between vehicle- and antagonist-treated rats 
never reached statistical significance. 
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after i.c.v. administration of each of the seven 
muscarinic antagonists tested was very similar and 
statistically indistinguishable from that of control 
rats receiving vehicle only (table 2). 
4. Discussion 
It is important to emphasize first that none of 
the musearlnie antagonists tested produced a sig-
nificant inhibition of [Ile5 ]angiotensin 11-induced 
drinking, even at the highest doses employed, 
versus carbachol-induced drinking (table 2). This 
finding provides evidence that the inhibition of 
carbachol-induced drinking that we observed can-
not be related to general behavioural impairment 
induced by the drugs. but is indeed the expression 
of a selective interaction with the cholinergic 
mechanism controlling drinking. 
Concerning the characterization of the receptor 
subtype involved in carbachol-induced drinking, 
the present results suggest that M1 receptors, rather 
than other subtypes of muscarinic receptors, ap-
parently mediate the response. The possibility that 
M 2 receptor are involved is ruled out by the 
inactivity of the M 2-selective muscarinic antago-
nist, methoctramine, in our test. This finding is in 
keeping with our previous results (Massi et al., 
1989), as weil as with the report of Schiavone et al. 
(1989) who used the M2 antagonist. AF-DX 116. 
Moreover, the selective M 3 antagonist. p-fluoro-
hexahydro-sila-difenidol, slightly inhibited drink-
ing only at the very high dose of 80 nmoljrat, 
arguing against the involvement of an M 3 recep-
tor. Finally. the observation that, as reported in 
table I. the five antagonists that inhibited 
carbachol-induced drinking effectively showed a 
good correlation between inhibitory potency in 
our test and affinity for the M1 receptor in rabbit 
vas deferens is direct evidence in favour of the 
mediation of the effect by an M 1 receptor. In fact: 
(a) pirenzepine, hexahydro-sila-difenidol and o-
methoxy-sila-hexocyclium have pA 2 values for M1 
receptors clearly higher than those of methoctra-
mine and of p-fluoro-hexahydro-sila-difenidol, 
which were clearly less potent to inhibit 
carbachol-induced drinking; (b) pirenzepine, 
hexahydro-sila-difenidol and o-methoxy-sila-
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hexocyclium, which have very similar pA 2 values 
(from 7.92 to 8.31), proved to be essentially 
equipotent in ouT test; (c) 4-DAMP and (R)-tri-
hexyphenidyl, which have pA 2 values foT M1 Te-
ceptors higheT than those of the pTeviously men-
tioned antagonists, weTe also moTe potent in ouT 
test. lndeed, 4-DAMP pToved to be slightly more 
potent than (R)-tTihexyphenidyl although its affin-
ity foT M1 Teceptors is about one order of magni-
tude loweT in functional studies (table 1). How-
ever, in binding experiments using NB-OK 1 cells, 
4-DAMP and (R)-trihexyphenidyl competed 
equipotently with N-methylscopolamine at M 1 re-
ceptors (pKi = 9.1 and 9.0, respectively) (Wael-
broeck et al., 1988; 1989). The pA 2 values for M 2 
and M 3 receptors of the seven antagonists tested 
aTe not related to theiT potency for inhibition of 
carbachol-induced drinking (table 1). 
The conclusion from the present study is not 
consistent with that drawn from a previous one 
(Hagan et al., 1987) which suggested that M 2 
andjor M3 receptors would mediate cholinergic 
drinking in the rat. Indeed, the results in this 
report are not strictly comparable to ours, since 
these authors injected theiT substances diTectly 
into the lateral hypothalamus adjacent to the peri-
fornical Tegion, while our drugs were injected into 
the ventricular space. PTobably, following i.c.v. 
injection, drugs Teach only to a slight extent the 
lateral hypothalamus while they can act at other 
sites such as the subfornical oTgan, which is very 
sensitive to the dipsogenie action of carbachol 
and, also is easily accessible fTom the ventTicular 
space. HoweveT, the different conclusion reached 
might have been a consequence of differences in 
pharmacological tools employed. In fact, Hagan et 
al. (1987) based their conclusions largely on the 
findings obtained with muscarinic agonists, while 
we used only antagonists. Our choice was related 
to the fact that putative M 1 agonists exhihit low 
efficacy and behave as partial agonists in a range 
of pharmacological and biochemical tests. Dif-
ferences in efficacy due to variations in intrinsic 
activity or efficiency of receptor coupling, may 
give a false impression of Teceptor specificity. 
MoTeover, our study involved a greater variety of 
antagonists, including the most recent and selec-
tive M 2 and M 3 antagonists, methoctramine and 
p-fluoro-hexahydro-sila-difenidol, which gave 
clear-cut support to our hypothesis of the involve-
ment of M1 receptors in cholinergic-induced 
drinking. 
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